troubleshooting 2026-05-31 11 min read the underwriting desk

Stripe declines on peptide checkout: how to fix them

3-minute scan
  • Most peptide checkout declines fall into three buckets: issuer declines you cannot fix, AVS/CVV declines you can, and Stripe-side review declines that signal a coming freeze.
  • A sudden spike in declines on a peptide store is usually Stripe flagging your account, not a card problem.
  • You can tune AVS and retry logic to recover real declines, but if Stripe is reviewing your peptide account, fixing declines is treating a symptom.
On this page

    Your peptide checkout was converting fine on Tuesday. By Thursday, one in three card attempts comes back declined, your conversion rate cratered, and customers are emailing that their card "did not work" even though it works everywhere else. You log into Stripe and see a wall of do_not_honor and generic decline codes. The instinct is to blame the customers cards. Usually it is not the cards. When declines spike on a peptide store overnight, it is almost always the account, not the buyer. Here is how to read the codes, fix the ones you can, and recognize the ones that mean your account is about to close.

    First, separate the three kinds of declines

    Not all declines are the same problem. Before you change anything, pull your declined transactions from Stripe and sort them by decline code. They fall into three buckets, and each has a completely different fix.

    • Issuer declines. The customer bank said no. Insufficient funds, card expired, do_not_honor from the issuer. You cannot fix these directly, but smart retry logic recovers some.
    • Verification declines. AVS mismatch, CVV mismatch, postal code fail. These are configuration on your side and are the most recoverable.
    • Processor declines. Stripe itself is blocking or reviewing the charge. These are the ones that matter most for a peptide operator because they signal an account problem, not a card problem.

    If your declines are mostly the third bucket and they appeared suddenly, stop reading about AVS tuning and skip to the account-review section. You have a bigger problem than checkout configuration.

    Sorting takes ten minutes and saves you from solving the wrong problem. Export the last 30 days of declined charges, group by decline code, and then group again by issuing bank. The two-axis view is what tells the story. A pile of incorrect_zip across many banks is a configuration problem you fix today. A pile of do_not_honor concentrated in a few banks is normal issuer behavior. A pile of generic_decline and processing_error spread evenly across dozens of banks that all appeared the same week is the account being throttled. Same raw decline count, three completely different responses. Do not skip the sort and start changing settings on a hunch.

    Decode the codes that actually appear on peptide stores

    Decline codeWhat it usually meansFixable by you?
    do_not_honorIssuer blanket decline, often risk-flaggedPartially, via retry
    incorrect_cvcCVV mismatch or CVV check failingYes
    incorrect_zipAVS postal code mismatchYes
    insufficient_fundsCustomer balance too lowVia retry timing
    card_velocity_exceededToo many attempts on one cardYes
    processing_errorStripe-side issue or review holdNo, escalate
    generic_declineIssuer or Stripe risk, no detail givenInvestigate

    The pattern to watch for: a spike concentrated in do_not_honor and generic_decline across many different issuers at once. One bank declining is a card problem. Every bank declining the same day is your account being throttled or reviewed.

    Fix the verification declines first, they are the easy wins

    AVS and CVV declines are configuration. If your gateway is set to reject any AVS mismatch, you are declining legitimate customers whose billing address has a typo or who moved recently. Peptide buyers are not less honest than other buyers, but they are more likely to use a card with a stale address.

    Loosen AVS to accept a street match even when the postal code does not, and let CVV be the hard gate. Watch your fraud rate for two weeks after the change. If chargebacks do not move, you just recovered a chunk of false declines. If they climb, tighten back. The fraud filter tuning guide covers the exact thresholds to start from.

    One filter worth a second look is your velocity check. Velocity rules cap how many attempts a single card, IP, or device can make in a window, and they exist to stop card testing. But peptide stores with returning subscription customers and shared household cards trip overly tight velocity rules constantly. A wife and husband on the same card, a customer retrying after a typo, a returning buyer on a new order the same day, all look like velocity abuse to a blunt rule. If your velocity threshold is set low, raise it incrementally and watch whether card_velocity_exceeded declines fall without fraud rising. Most stores leave money on the table here because the default was tuned for a generic low-risk merchant, not a peptide subscription book.

    Build retry logic that recovers real declines

    Issuer declines like insufficient_funds and some do_not_honor codes are temporary. A failed charge retried two days later on a payday cycle often clears. This matters most for subscription peptide businesses where a failed rebill is lost revenue, not just a lost cart.

    Use a dunning sequence: retry on day 1, day 3, and day 7, with an email to the customer between attempts. Do not retry the same card more than a few times in a short window or you trigger card_velocity_exceeded and make it worse. Smart dunning recovers 30-50% of soft declines on subscriptions. The dunning recovery playbook has the full sequence.

    The decline spike that means Stripe is reviewing you

    Here is the one that is not a checkout problem. Stripe declines peptides per its acceptable use policy. When Stripe risk flags a peptide account, one of the early signals is a quiet rise in processor-side declines before any freeze email arrives. Stripe starts throttling questionable charges while a human reviews the account.

    If you see processing_error and generic_decline climbing across many issuers, a drop in your authorization rate with no change to your traffic, and it started without any code change on your side, that is the pattern. You are not fixing a checkout. You are watching the early warning of an account review. Read why Stripe is not built for peptide operators so you understand what is happening, and pull your data now while the dashboard still exports cleanly.

    Check the obvious gateway settings before you panic

    Before you conclude your account is under review, rule out the boring causes. A surprising share of sudden decline spikes trace to a configuration change nobody flagged. Someone updated the checkout plugin and the new version defaults AVS to strict. A currency or country setting got toggled. A test mode key got left in place after a deploy. Your fraud filter got a new rule that is firing on legitimate traffic. Walk the recent change log on your store and gateway before you assume the worst.

    Also check whether the spike correlates with a traffic source. If a single affiliate or ad campaign started sending lower-quality traffic, the declines may be real issuer declines concentrated in that segment, not an account problem at all. Segment your declines by traffic source the same way you segmented by decline code and issuer. If one campaign accounts for most of the bad attempts, the fix is the campaign, not the gateway. Eliminating these mundane causes first saves you from a needless migration and tells you clearly when the remaining declines really are processor-side.

    What not to do when declines spike

    • Do not open a second Stripe account to route the declined traffic. Stripe links accounts by principal, banking, and device. The second one closes as a linked account and now you have two terminations.
    • Do not relabel your products as supplements to look lower risk. Stripe reviews your live site and marketing. Misrepresentation is a faster path to closure than the declines you are trying to fix.
    • Do not hammer the same cards with rapid retries. You will trigger velocity declines and inflate your decline rate further.
    • Do not ignore a sudden authorization-rate drop. On a peptide store that is the canary, not noise.

    The real fix is not on Stripe at all

    You can tune AVS, build dunning, and recover the verification and soft declines. That is worth doing on any store. But if the root cause is that Stripe is reviewing a peptide account it never wanted, every hour spent on checkout configuration is treating a symptom. The durable fix is processing on an acquirer that actually approves peptides, where a decline is a card problem and not a countdown.

    For a single-brand peptide operator that means a specialist ISO on an Authorize.net or NMI gateway. For an operator running three or more peptide brands, it can mean a parent account with brand-level descriptors and failover routing across acquirers, so a decline on one path can retry on another. multiflow runs that orchestration layer on top of your acquirers. We do not process the payment ourselves and we do not onboard single-brand operators, but we can tell you which path fits. The peptide operators overview lays out what an acquirer that actually wants the vertical changes about your decline picture.

    It is worth being concrete about how different the decline experience is on the right acquirer. On a peptide-friendly acquirer, your declines collapse back to the first two buckets: real issuer declines and verification declines you can tune. The processor-side bucket, the throttling and review holds that have no fix, largely disappears because the acquirer underwrote you as a peptide merchant on purpose. You stop firefighting a decline rate that creeps every time a risk model gets nervous. The side-by-side in multiflow vs Stripe for peptides shows what changes when the platform underneath your checkout is built for the vertical instead of tolerating it until it is not.

    If your peptide checkout declines are really the leading edge of a Stripe review, the move is to migrate before the freeze, not after. Talk to an underwriter for an honest read on whether you have a checkout problem or an account problem.

    Found this useful? Share it X LinkedIn Reddit HN Email

    FAQ

    Why did my peptide checkout decline rate spike overnight?
    A sudden, broad decline spike across many different card issuers on the same day is rarely a card problem. It is usually your processor throttling or reviewing the account. Stripe declines peptides per its acceptable use policy, and rising processor-side declines often precede a freeze email by days or weeks. Pull your declined transactions, sort by code, and if processing_error and generic_decline dominate across many banks, treat it as an account review and export your data now.
    How do I fix do_not_honor declines on peptide cards?
    do_not_honor is an issuer blanket decline, so you cannot fix it directly at checkout. What you can do is retry on a delay, since some are temporary holds tied to the customer balance or a transient risk flag. Retry on day 1, day 3, and day 7 with an email between attempts, and never hammer the same card in a short window or you trigger card_velocity_exceeded. If do_not_honor is spiking across many issuers at once, suspect your account, not the cards.
    Will loosening AVS increase my chargebacks?
    It can, which is why you test it. Loosen AVS to accept a street-address match even when the postal code mismatches, keep CVV as a hard gate, then watch your chargeback ratio for two weeks. Many peptide buyers fail AVS on a stale billing address, not because they are fraudulent. If chargebacks stay flat you recovered real customers. If they climb, tighten back. Keep the change small and measured rather than turning AVS off entirely.
    Can retry logic really recover failed peptide subscription rebills?
    Yes. Soft declines like insufficient_funds and some do_not_honor codes are temporary, and a well-timed retry clears many of them. A dunning sequence retrying on day 1, 3, and 7 with customer emails recovers roughly 30-50% of soft declines on subscriptions. The key is timing retries around customer paydays and capping attempts so you do not trigger velocity declines. For peptide subscription brands this is direct revenue recovery, not just a nicer checkout.
    Should I switch to a different gateway if declines stay high?
    If the declines are verification or soft issuer declines, no, fix those with AVS tuning and dunning first. If the declines are processor-side and your account is being reviewed because you sell peptides, then yes, the durable fix is an acquirer that approves peptides. A single-brand operator moves to a specialist ISO. A multi-brand operator can move to a parent account with failover routing. Either way, migrate while your current account still exports data cleanly.
    Is a high decline rate a reason Stripe will close my account?
    A high decline rate is often a symptom of the closure rather than its cause. Stripe is more likely closing the account because it is a peptide account that violates the acceptable use policy, and the throttled declines are part of the review. That said, a genuinely high decline rate from bad fraud filters or sloppy retries does raise risk scores everywhere. Clean up the controllable declines, but understand that on Stripe the underlying issue is the vertical.

    Running multiple brands?
    multiflow was built for this.

    The Operator Briefing

    Twice-monthly. No fluff.

    Processor shutdowns, reserve-hold playbooks, reconciliation lessons, and the merchant-account decisions that save operators six-figure years. Delivered to your inbox — never spam.

    No spam. Unsubscribe in one click.

    We use essential cookies · Privacy